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Abstract
Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailabil-
ity is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high ex-
pression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis
and vasodilation; thus, a protective role of insulin on high D-glucose–alterations in endothe-
lial function is likely. Vascular reactivity to U46619 (thromboxane A2 mimetic) and calcitonin
gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein
rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose.
hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein ki-
nases (p42/44mapk), protein kinase B/Akt (Akt) expression and activity were determined by
western blotting and qRT-PCR, tetrahydrobiopterin (BH4) level was determined by HPLC,
and L-arginine transport (0–1000 μmol/L) was measured in response to 5–25 mmol/L D-glu-
cose (0–36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs). Assays
were in the absence or presence of insulin and/or apocynin (nicotinamide adenine dinucleo-
tide phosphate-oxidase [NADPH oxidase] inhibitor), tempol or Mn(III)TMPyP (SOD
mimetics). High D-glucose increased hCAT-1 expression and activity, which was biphasic
(peaks: 6 and 24 hours of incubation). High D-glucose–increased maximal transport veloci-
ty was blocked by insulin and correlated with lower hCAT-1 expression and SLC7A1 gene
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promoter activity. High D-glucose–increased transport parallels higher reactive oxygen spe-
cies (ROS) and superoxide anion (O2
•–) generation, and increased U46619-contraction and
reduced CGRP-dilation of vein rings. Insulin and apocynin attenuate ROS and O2
•– genera-
tion, and restored vascular reactivity to U46619 and CGRP. Insulin, but not apocynin or tem-
pol reversed high D-glucose–increased NO synthesis; however, tempol and Mn(III)TMPyP
reversed the high D-glucose–reduced BH4 level. Insulin and tempol blocked the high D-glu-
cose–increased p42/44mapk phosphorylation. Vascular dysfunction caused by high D-glu-
cose is likely attenuated by insulin through the L-arginine/NO and O2
•–/NADPH oxidase
pathways. These findings are of interest for better understanding vascular dysfunction in
states of foetal insulin resistance and hyperglycaemia.
Introduction
Hyperglycaemia and diabetes mellitus are pathological conditions associated with foetal endo-
thelial dysfunction [1–4] and type 2 diabetes mellitus (T2DM) [5] or cardiovascular disease
(CVD) [6, 7] in adulthood. CVD in patients with diabetes mellitus is associated with the gener-
ation of reactive oxygen species (ROS) [8] caused by chronic hyperglycaemia [3] and insulin
resistance [9]. Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) activi-
ty and endothelial nitric oxide (NO) synthase (eNOS) uncoupling leads to vascular ROS gener-
ation [10], of which superoxide anion (O2
•–) reduces NO bioavailability, generating
peroxynitrite (ONOO–) and resulting in altered vascular endothelial function [11]. NO is
synthesised by eNOS from the cationic amino acid L-arginine, which is taken up from the ex-
tracellular space by the human cationic amino acid transporter 1 (hCAT-1), a member of the
cationic amino acid transporter (CATs) family [11], in human umbilical vein endothelial cells
(HUVECs) [12]. Thus, NO bioavailability depends on eNOS activity and hCAT-1 expression
and activity [13], as well as ROS levels [11], in this cell type.
Elevated extracellular D-glucose increases hCAT-1-mediated L-arginine transport and NO
synthesis (the ‘L-arginine/NO pathway’) [14, 15] as well as intracellular ROS generation [16,
17], leading to endothelial dysfunction [2]. Insulin causes human umbilical vein endothelium-
dependent dilation and increases hCAT-1 expression caused by elevated SLC7A1 (encoding
hCAT-1) transcriptional activity [12, 14, 18] and NO synthesis [12]. Additionally, insulin re-
verses the gestational diabetes mellitus (GDM) or high D-glucose-associated stimulation of the
L-arginine/NO pathway in HUVECs [11]. We hypothesise that insulin has a beneficial antioxi-
dant capacity that reverses the high D-glucose-associated increase in ROS generation. We stud-
ied the effect of high extracellular D-glucose on insulin modulation of the L-arginine/NO and
NADPH oxidase/O2
•– pathways in fetoplacental vascular reactivity. The results suggest that
D-glucose-increased oxidative stress and vascular dysfunction are attenuated by insulin. Thus,
insulin likely acts as an antioxidant under conditions of hyperglycaemia, leading to protection
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Human placenta and cell culture
Placentas with their umbilical cords were collected after delivery from 33 full-term normal
pregnancies from the Hospital Clínico Universidad Católica in Santiago (Chile) and from the
Hospital Regional Guillermo Grant Benavente in Concepción (Chile). All of the pregnancies
were single births. The pregnant women did not smoke or consume drugs or alcohol and had
no intrauterine infection or any medical or obstetrical complications. The women were normo-
tensive and have normal weight and exhibited a normal response to the oral glucose tolerance
test. They were under a normal food regimen during the entire pregnancy period. In addition,
the new-borns (46% female, 54% male) were born at term by vaginal delivery and were of nor-
mal birth weight and height.
The placentas were transported in a sterile container (4°C) to the laboratory. Sections of
umbilical cords (100–120 mm length) were collected into sterile 200 mL phosphate-buffered
saline (PBS) solution ((mmol/L): 130 NaCl, 2.7 KCl, 0.8 Na2HPO4, 1.4 KH2PO4 (pH 7.4, 4°C))
and used for the isolation of HUVECs between 6–12 hours after delivery [12].
The HUVECs were isolated by collagenase digestion (0.25 mg/mL Collagenase Type II from
Clostridium histolyticum; Invitrogen, Carlsbad, CA, USA) as previously described [12]. The cells
were cultured (37°C, 5% CO2) to passage 3 in medium 199 (M199) (Gibco Life Technologies,
Carlsbad, CA, USA) containing 5 mmol/L D-glucose, 10% new-born calf serum (NBCS), 10%
foetal calf serum (FCS), 3.2 mmol/L L-glutamine, and 100 U/mL penicillin-streptomycin (prima-
ry culture medium, PCM). The experiments were performed on the cells incubated (0–24 hours)
in PCM containing increasing concentrations of D-glucose (5, 10, 15, 20 or 25 mmol/L) in the
absence or presence (8 hours) of insulin (0.001, 0.01, 0.1, 1 or 10 nmol/L). In the experiments in
which the time of exposure to D-glucose was longer than 8 hours, insulin was added for the final
8 hours of incubation. In some experiments, the cells were incubated with 5 mmol/L D-glucose
+ 20 mmol/L D-mannitol or 20 mmol/L L-glucose. The cell viability estimated by Trypan blue
exclusion was>97%. Sixteen hours prior to the experiments, the incubation medium was
changed to serum-free M199 [12].
L-Arginine transport
The overall L-arginine transport (3 μCi/mL L-[3H]arginine (NEN, Dreieich, FRG), 0–
1000 μmol/L L-arginine, 1 minute, 37°C) was measured as described [12, 14, 18]. Briefly, the
transport assays were performed in Krebs solution ((mmol/L): NaCl 131, KCl 5.6, NaHCO3 25,
NaH2PO4 1, HEPES 20, CaCl2 2.5, MgCl2 1 (pH 7.4, 37°C)) in cells preincubated (12 hours)
in PCM containing 2% sera and different concentrations of D-glucose, 5 mmol/L D-glucose +
20 mmol/L D-mannitol or 5 mmol/L D-glucose + 20 mmol/L L-glucose. The cell monolayers
were rinsed with ice-cold Krebs solution to terminate the tracer uptake. The radioactivity in
the formic acid cell digests was determined by liquid scintillation counting, and the uptake was
corrected for D-[3H]mannitol (NEN) disintegrations per minute (d.p.m.) in the extracellular
space [12].
The overall transport at initial rates (i.e., the linear uptake up to 1 minute) was adjusted to
the Michaelis-Menten hyperbola with a nonsaturable, lineal component as described [12, 18].
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The maximal velocity (Vmax) and apparent Michaelis-Menten constant (Km) of saturable trans-
port were calculated as described [12, 14, 18].
Western blotting
Total protein was obtained from the confluent cells, washed twice with ice-cold PBS and har-
vested in 100 μL of lysis buffer (63.7 mmol/L Tris/HCl (pH 6.8), 10% glycerol, 2% sodium
dodecyl sulphate, 1 mmol/L sodium orthovanadate, 50 mg/mL leupeptin, 5% 2-mercaptoetha-
nol) as described [12]. The cells were sonicated (six cycles, 5 seconds, 100 W, 4°C), and total
protein was separated by centrifugation (12,000 rpm, 15 minutes, 4°C). The proteins (50 μg)
were separated by polyacrylamide gel (8–10%) electrophoresis and transferred to Immobilon-P
polyvinylidene difluoride membranes (BioRad Laboratories, Hertfordshire, UK). The proteins
were then probed with primary monoclonal mouse anti-hCAT-1 (1:1500, 12 hours, 4°C)
(Sigma-Aldrich, St. Louis, MO, USA), primary polyclonal goat anti-total and phosphorylated
mitogen-activated 42 and 44 kDa protein kinases (p42/44mapk, 1:1000) or protein kinase B/Akt
(Akt, 1:1000) (Cell Signalling, Danvers, MA, USA) or monoclonal mouse anti-ß-actin (1:2000,
1 hour, room temperature) (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies. The
membranes were rinsed in Tris-buffered saline with Tween (TBS-T) and incubated (1 hour) in
TBS-T/0.2% bovine serum albumin (BSA) containing secondary horseradish peroxidase-con-
jugated goat anti-mouse (AbCam, Cambridge, MA, USA) or anti-goat (Santa Cruz Biotechnol-
ogy) antibodies. Proteins were detected by enhanced chemiluminescence (film exposure time
was 2 min) in a ChemiDoc-It 510 Imagen System (UVP, LCC Upland, CA, USA) and quanti-
fied by densitometry as described [12].
Immunofluorescence and confocal laser scanning microscopy
The HUVECs were grown on microscope cover slips (106 cells/slide) (Marienfeld GmbH &
Co. KG, LaudaKönigshofen, Baden-Württemberg, Germany) in PCM to 90% confluence. The
cells were cultured for 24 hours in PCM containing 25 mmol/L D-glucose in the absence or
presence of 1 nmol/L insulin (see above). The cells were then fixed in 4% paraformaldehyde
(15 minutes), rinsed (x3) with Hanks solution ((mmol/L): CaCl2 1.26, KCl2 5.37, KH2PO4 0.44,
MgSO4 8.11, NaCl 136.89, Na2HPO4 0.33, NaHCO3 4.16 (37°C, pH 7.4)), permeabilized with
0.1% Triton X-100 (20 minutes), and blocked (1 hour) with 1% BSA. hCAT-1 was immunolo-
calized by incubating the cells with primary polyclonal rabbit anti-hCAT-1 (1:1500, overnight
at 4°C) in PBS containing 5% BSA. The fixed cells were then washed (x3) with Hanks solution
followed by incubation (1 hour) with the secondary antibody, fluorescein isothiocyanate
(FITC) goat anti-mouse IgG (H+L) (λexc/λem:492/520 nm) (1:2000) (Thermo Fisher Scientific,
Inc., Waltham, MA, USA) in PBS containing 5% BSA. The nuclei were counterstained with
Vectashield mounting medium and stained with 4’,6-diamidino-2-phenylindole (DAPI) (Vec-
tor Laboratories, Burlingame, CA, USA). The samples were analysed under an Olympus IX81
microscope with a disk scanning unit (DSU) spinning disk confocal system (Olympus, Tokyo,
Japan). The images were obtained with a Hamamatsu ORCA-R2 camera (Hamamatsu Photon-
ics, Hamamatsu, Japan) controlled by the Olympus XcellenceR software using a Plan Apo N
60x 1.42 NA objective. Each sample was examined through successive 0.2 μm optical slices
along the z axis, and the obtained images were post-processed by applying a Wiener filter
deconvolution provided by the Olympus software.
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Total RNA isolation and reverse transcription
Total RNA was isolated using the Chomczynski method as previously described [12]. The
RNA quality and integrity were ensured by gel visualisation and spectrophotometric analysis
(OD260/280), quantified at 260 nm and precipitated to obtain 4 μg/μL RNA. Aliquots (1 μg) of
the total RNA were reverse transcribed into cDNA as described [14, 18, 19].
Quantitative RT-PCR
The experiments were performed using a LightCycler rapid thermal cycler (Roche Diagnostics,
Lewes, UK) in a reaction mixture containing 0.5 μmol/L primers, dNTPs, Taq DNA polymer-
ase and reaction buffer provided in QuantiTectSYBR Green PCRMaster Mix (QIAGEN, Craw-
ley, UK) as described [8, 18, 19]. Hot Start Taq DNA polymerase was activated (15 minutes,
95°C), and the assays included 95°C denaturation (15 seconds), annealing (20 seconds) at 54°C
(hCAT-1 and 28S), and extension (10 seconds) at 72°C (hCAT-1 and 28S). The product melt-
ing temperatures were 79.1°C (hCAT-1) and 86.7°C (28S). The following oligonucleotide prim-
ers were used: hCAT-1 (sense) 5’-GAGTTAGATCCAGCAGACCA-3’, hCAT-1 (anti-sense)
5’-TGTTCACAATTAGCCCAGAG-3’, 28S (sense) 5’-TTGAAAATCCGGGGGAGAG-3’, 28S
(anti-sense) 5’-ACATTGTTCCAACATGCCAG-3’. The number of copies of 28S rRNA was
not significantly altered (P> 0.05, n = 4) in any experimental conditions used in this study.
Actinomycin D effect on hCAT-1 mRNA
Total RNA and protein were isolated from the HUVECs cultured in PCM containing 5 or
25 mmol/L D-glucose (24 hours) in the absence or presence (8 hours) of 1.5 μmol/L actinomy-
cin D (transcription inhibitor) [20] and/or 1 nmol/L insulin. The hCAT-1mRNA and 28S
rRNA were quantified by real-time RT-PCR.
hCAT-1 promoter cloning
The upstream sequences -1606 and -650 bp from the transcription start codon of the SLC7A1
gene (GenBank: AL596114) were PCR-amplified and cloned into the pGL3-basic reporter sys-
tem to generate the pGL3-hCAT1-1606 and pGL3-hCAT1-650 reporter constructs as described
[12, 18, 19].
Transient transfection
Sub-confluent (60–80%) HUVECs primary cultures were resuspended in serum-free M199. Al-
iquots of the cell suspension (0.5 mL, 3.2 x106 cells/mL) were mixed with 10 μg of the
pGL3-hCAT1-1606 or pGL3-hCAT1-650 constructs, pGL3-Basic (empty pGL3 vector),
pGL3-Control (Simian Virus 40 promoter (SV40) pGL3 vector), and the internal transfection
control vector, pRL-TK expressing Renilla luciferase (Promega) [19, 20]. After electroporation
(300 Volts, 700 μF, 5–10 milliseconds) (Gene Pulser II System, BioRad, CA, USA), the cells
were cultured (49 hours) in M199 containing 2% FCS. The transfection efficiency was estimat-
ed by transfection of the pEGFP-N3 vector (Clontech, Mountain View, CA, USA), and the
fluorescent cells were counted under an inverted fluorescent microscope (Leica DMIL; Wetzlar,
Germany) [19, 20].
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Luciferase assay
The electroporated cells were lysed in 200 μL of passive lysis buffer (Promega), and firefly and
Renilla luciferase activity were measured using the Dual-Luciferase Reporter Assay System
(Promega) in a Sirius luminometer (Berthold Detection System; Oak Ridge, TN, USA) [19, 20].
Intracellular ROS and NO
Intracellular ROS and NO levels were determined using the fluorescent dyes 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) and 4-amino-
5-methylamino-2',7'-difluorofluorescein (DAF-FM) (Molecular Probes, Leiden, The Nether-
lands), respectively. Confluent cells in a 100 mm2 plate were incubated with high D-glucose
(25 mmol/L, 24 hours) and/or insulin (1 nmol/L, 8 hours) and/or 1-(4-hydroxy-3-methoxy-
phenyl)-ethanone (apocynin, 100 μmol/L, 24 hours, NADPH oxidase inhibitor) and exposed
(45 minutes, 37°C) to 10 μmol/L of CM-H2DCFDA or DAF-FM in PBS (37°C, pH 7.4). The
fluorescence (λexc/λem: 495/510 nm) was determined in a Sinergy 2 (Biotek, Winooski, VT,
USA) microplate reader [21].
Tetrahydrobiopterin (BH4) determination by HPLC
The level of BH4 was determined by an acid-base oxidation method followed by fluorometric
detection by high performance liquid chromatography (HPLC). The total biopterins level
(BH4 + dihydrobiopterin (BH2) + biopterins) were determined by acid oxidation and BH2
+ biopterins levels by basic oxidation, following a modification of the method described by
Fukushima & Nixon [22]. Confluent HUVECs in 100 mm diameter culture plates in 5 or 25
mmol/L glucose in the absence or presence (24 hours) of 1 nmol/L insulin, 100 μmol/L apocy-
nin, 100 μmol/L Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (Mn(III)
TMPyP), or 1 mmol/L tempol were collected in cold PBS (4°C). Cells were then centrifuged
(1,000 g, 2 minutes, 4°C) and lysed in 200 μL of biopterins lysis buffer ((mmol/L): 50 Tris-HCl
(pH 7.4), 2 dithiothreitol (DTT), 1 ethylenediamine tetraacetic acid (EDTA)). Cells were then
sonicated (tree cycles, 10 seconds, 100W, 4°C) and centrifuged (13,500 g, 20 minutes, 4°C).
Proteins were quantified in 20 μL of the supernatants by a modified Lowry method (Bio-Rad
DC protein assay, BioRad Laboratories) as described [12]. Proteins contained in 180 μL of su-
pernatant were precipitated by mixing with 20 μL of 1.5 M HClO4:2 M H3PO4 = 1:1 (v/v) by
strong vortex (5 seconds), allowing 30 minutes (4°C) incubation and further centrifugation
(13,500 g, 5 minutes, 4°C). Aliquots of 90 μL of the protein-free supernatant were used for total
biopterins determination by acid oxidation with 10 μL of iodine/KI acid solution (1% iodine in
a 2% KI solution prepared in 1 MHCl). For BH2 + biopterins determination an alkali oxidation
was performed by mixing 10 μL of 1 M NaOH with 80 μL of protein-free supernatant, followed
by addition of 10 μL of iodine/KI alkali solution (1% iodine in a 2% KI solution prepared in 1
M NaOH). Samples for total biopterins and BH2 + biopterins determination were incubated at
23°C for 1 hour in darkness. After this incubation period iodine in the samples was reduced by
adding 5 μL of fresh ascorbic acid (20 mg/mL). Samples for BH2 + biopterins determination
were acidified by mixing with 20 μL of 1 M H3PO4. All samples (i.e., acid and alkali oxidation)
were centrifuged (13,500 g, 5 minutes, 23°C), passed through a Millex syringe-driven filter unit
(Millipore Corporation, Billerica, MA, USA) and loaded in an analytical column (C18: 4.6 mm
x 150 mm) (HiQsil, KYA Tech, Japan) coupled to a HPLC system (PU2089S, Jasco, Japan).
The analytical column was washed by passing through ultrapure water (Milli-Q, Millipore Cor-
poration) (pH 7.3, 23°C, 20 minutes) and further washed with methanol (>99%, 20 minutes).
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The column was then equilibrated with the mobile phase (5% methanol, 95% water) for 40
minutes with a flow rate of 1 mL/minute. Fluorescence was monitored at excitation and emis-
sion wavelengths of 350 and 450 nm, respectively, by using the fluorescent detector (FP 2020
Plus, Jasco, Japan) of the HPLC system. Biopterins were quantified against the standard curve
0–100 nmol/L L-biopterin (Sigma-Aldrich). The chromatograms were obtained and analysed
by using the software ChromPass 1.7 (ChromPass Chromatography Data System, Jasco,
Japan). BH4 was determined as the difference between the areas under the curve in chromato-





•– was quantified using lucigenin (Sigma-Aldrich) [23]. Confluent cells in
100 mm2 plates were incubated with high D-glucose (25 mmol/L, 24 hours) in the absence or
presence of insulin (1 nmol/L), apocynin (100 μmol/L, 24 hours) and/or 4-hydroxy 2,2,6,6,-tet-
ramethyl piperidine 1-oxyl (tempol; 1 mmol/L, 24 hours, superoxide dismutase (SOD)
mimetic), harvested, and centrifuged (1500 rpm, 5 minutes, 4°C), and the cellular pellet was re-
suspended and washed with PBS (pH 7.4, 4°C). A volume of 50 μL of resuspended cells was sta-
bilised (5 minutes, 25°C) and incubated with lucigenin (10 μmol/L, 30 minutes). The photon
emission was determined every 15 seconds for 10 minutes in a Sirius luminometer (Berthold
Detection System; Oak Ridge, TN, USA) [23].
Umbilical vein reactivity
Ring segments (2–4 mm length) from human umbilical veins were mounted in a myograph
(610MMultiwire Myograph System, Danish Myo Technology A/S, Denmark) for isometric
force measurements with the optimal diameter adjusted from the maximal active response to
90 mmol/L KCl, as described [12]. The vessels were incubated (24 hours, 37°C) with 5 or
25 mmol/L D-glucose, 5 mmol/L D-glucose + 20 mmol/L D-mannitol, 100 μmol/L apocynin,
1 nmol/L insulin and/or 1 mmol/L tempol. After this incubation period, the response to in-
creasing concentrations of U46619 (0.1–1000 nmol/L, 5 minutes) (thromboxane A2 analogue)
[12, 24] or calcitonin gene related peptide (CGRP, 0.001–100 nmol/L, 5 minutes) [12] (Sigma-
Aldrich) was assayed.
Statistical analysis
The values are the mean ± S.E.M. for different cell cultures (with 3–4 replicates) from an equal
number of placentas (n = 33). The data reported in this study describe a normal standard dis-
tribution. The comparisons between two or more groups were performed using Student’s un-
paired t-test and analysis of variance (ANOVA), respectively. If the ANOVA demonstrated a
significant interaction between the variables, post hoc analyses were performed by the multiple-
comparison Bonferroni correction test. The GraphPad Instat 3.0b and GraphPad Prism 6.0f
(GraphPad Software, Inc., San Diego, CA, USA) statistical software packages were used for the
data analysis. P<0.05 was considered significant.
Results
High D-glucose increases L-arginine uptake and hCAT-1 expression
High D-glucose increased L-arginine transport in a concentration- and time-dependent man-
ner (Fig 1A). The D-glucose effect was biphasic, with an initial increase from 2 hours of
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Fig 1. Temporal increase of hCAT-1 expression and activity by high D-glucose. A, Uptake of 100 μmol/L
L-arginine (2 μCi/mL L-[3H]arginine, 1 minute, 37°C) in HUVECs preincubated in Krebs solution containing
different concentrations of D-glucose, or 5 mmol/L D-glucose + D-mannitol or L-glucose. B, hCAT-1 protein
abundance and mRNA expression in 25 mmol/L D-glucose. Western blot is representative of other 10
experiments for hCAT-1 and β-actin (internal reference) proteins. In A lines are the mean values adjusted to a
fifth-order polynomial model. In B the segmented lines represent the mean values for protein abundance
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incubation reaching a maximal first increase at 8 hours of incubation. The L-arginine transport
was unaltered at 16 hours, but it increased at 24 hours of incubation. The kinetics for a primary
peak half-stimulatory effect (ppSE50) were similar for 10 and 15 mmol/L as well as for 20 and
25 mmol/L D-glucose (Table 1). The ppSE50 values for 10 and 15 mmol/L were higher than the
values for 20 and 25 mmol/L D-glucose. However, the kinetics for the secondary peak half-
stimulatory effect (spSE50) was similar at all D-glucose concentrations. The half-maximal stim-
ulatory concentration (SC50) of D-glucose at 24 hours of incubation on L-arginine transport
was 14.1 ± 2.1 mmol/L. Transport was unaltered in cells incubated with 5 mmol/L D-glucose +
20 mmol/L D-mannitol or 5 mmol/L D-glucose + 20 mmol/L L-glucose (Fig 1A). Because a
(light blue) or mRNA expression (yellow) as in A. *P<0.04 versus corresponding values at 0 hours. Values
are mean ± S.E.M. (n = 5–10).
doi:10.1371/journal.pone.0122398.g001
Table 1. Effect of D-glucose on L-arginine transport in HUVECs.





D-Glucose 5 – – –
D-Glucose 10 3.9 ± 0.3 23 ± 0.5 5.9 ± 0.3
D-Glucose 15 4.1 ± 0.2 23 ± 0.4 5.6 ± 0.2
D-Glucose 20 1.9 ± 0.2* 22 ± 0.4 11.6 ± 0.7*
D-Glucose 25 2.9 ± 0.1* 20.8 ± 0.5 7.2 ± 0.1*
D-Glucose 5 + L-glucose 20 – – –
D-Glucose 5 + D-mannitol 20 – – –
Change in hCAT-1 mRNA expression
D-Glucose 25 1.7 ± 0.1 22.2 ± 0.2 13.1 ± 0.5
Change in hCAT-1 protein abundance
D-Glucose 25 3.0 ± 0.2† 22.5 ± 0.3† 7.5 ± 0.3
L-Arginine transport kinetics
Vmax (pmol/μg protein/minute) Km (μmol/L) Vmax/Km (pmol/μg protein/minute/(μmol/L))
D-Glucose 5 2.6 ± 0.3 123 ± 43 0.021 ± 0.005
D-Glucose 25 10.3 ± 0.7* 196 ± 36 0.053 ± 0.011*
D-Glucose 25 + insulin 0.01 9.8 ± 1.2* 150 ± 59 0.065 ± 0.017*
D-Glucose 25 + insulin 0.1 6.7 ± 0.5* 122 ± 28 0.055 ± 0.009*
D-Glucose 25 + insulin 1 1.7 ± 0.2† 117 ± 58 0.015 ± 0.005†
D-Glucose 25 + insulin 10 3.0 ± 0.2† 127 ± 28 0.024 ± 0.003†
D-Glucose 5 + L-glucose 20 + insulin 1 8.1 ± 0.6† 121 ± 36 0.067 ± 0.012†
D-Glucose 5 + D-mannitol 20 + insulin 1 8.3 ± 0.8† 136 ± 41 0.061 ± 0.012†
L-Arginine uptake (100 μmol/L) in HUVECs exposed (0–24 hours) to Krebs solution with increasing concentrations of D-glucose, or 5 mmol/L D-glucose
+ 20 mmol/L L-glucose or 20 mmol/L D-mannitol (see Methods). Kinetics of saturable L-arginine transport (0–1000 μmol/L L-arginine, 2 μCi/mL L-[3H]
arginine, 1 minute, 37°C) in cells exposed (24 hours) to Krebs solution containing 5 or 25 mmol/L D-glucose with insulin (0.01–10 nmol/L) (8 hours), or
5 mmol/L D-glucose + 20 mmol/L L-glucose or 20 mmol/L D-mannitol (see Methods). Vmax/Km: maximal transport capacity,
ppSE50: primary peak half-
stimulatory D-glucose effect, spSE50: secondary peak half-stimulatory D-glucose effect, hCAT-1: human cationic amino acid transporter 1.—denotes not
signiﬁcant change.
*P<0.05 versus 5 mmol/L D-glucose
†P<0.05 versus 25 mmol/L D-glucose. Values are means ± S.E.M. (n = 10–12).
doi:10.1371/journal.pone.0122398.t001
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significant increase in transport by 25 mmol/L D-glucose (hereafter referred as ‘high D-glu-
cose’) was observed starting at approximately 2 hours of incubation and maintained for at least
24 hours, we assayed the insulin effect in the cells incubated with this concentration of D-glu-
cose for 24 hours. Additionally, hCAT-1mRNA expression and protein abundance increased
in a biphasic manner upon high D-glucose treatment (Fig 1B). The ppSE50 and
spSE50 values of
hCAT-1mRNA expression were lower than the corresponding values for hCAT-1 protein
abundance (Table 1).
Insulin blocks D-glucose–increased hCAT-1 activity and expression
We previously reported that insulin increases the Vmax of L-arginine transport, without altering
the apparent Km, in a concentration-dependent manner in HUVECs cultured in 5 mmol/L D-
glucose [12]. The high D-glucose effect was reflected in a higher Vmax/Km, with a maximal
transport increase at 1 nmol/L insulin [12]. Insulin blocked the increase in L-arginine transport
caused by high D-glucose in a concentration-dependent manner by decreasing the Vmax
(Fig 2A) and Vmax/Km (Table 1) values of transport, with a half-maximal inhibitory concentra-
tion (IC50) for an insulin effect of 0.11 ± 0.007 nmol/L (Fig 2B).
Insulin restored the increase in hCAT-1 protein abundance (Fig 3A), hCAT-1mRNA ex-
pression (Fig 3B) and fluorescence (Fig 3C). In addition, high D-glucose and insulin increased
these parameters in cells in 5 mmol/L D-glucose. Actinomycin D blocked the effect of high
D-glucose on hCAT-1mRNA expression (Fig 3D). In addition, incubation of cells with high
D-glucose increased SLC7A1 promoter transcriptional activity in cells transfected with either
pGL3-hCAT1-650 (1.39 ± 0.08-fold) or pGL3-hCAT1-1606 (1.46 ± 0.05-fold) constructs com-
pared with non-transfected cells in 5 mmol/L D-glucose (Fig 3E). Insulin increased the tran-
scriptional activity only in cells transfected with pGL3-hCAT1-1606 (1.37 ± 0.06-fold).
However, insulin reverted the effect of high D-glucose on SLC7A1 transcriptional activity for
cells containing each construct.
Insulin blocks D-glucose–increased ROS and NO synthesis
D-Glucose increased ROS formation (SC50 = 9.9 ± 0.5 mmol/L), an effect abolished by apocy-
nin and insulin (Fig 4A). High D-glucose also increased O2
•– generation, which was abolished
by apocynin, insulin and/or tempol (Fig 4B). High D-glucose and insulin increased the NO
level in cells in 5 mmol/L D-glucose; however, insulin but not apocynin or tempol blocked the
high D-glucose-mediated increase in the NO level (Fig 4C).
SODmimetics block D-glucose–reduced BH4 level
HUVECs exposed to high D-glucose show lower BH4 level compared with cells in 5 mmol/L
D-glucose, an effect unaltered by insulin or apocynin (Fig 4D). However, the SODmimetics
tempol and Mn(III)TMPyP increased the BH4 level to comparable values in cells in 5 or
25 mmol/L D-glucose.
Insulin and tempol block D-glucose–increased p42/44mapk
phosphorylation
In cells in 5 mmol/L D-glucose insulin increased p42/44mapk (Fig 5A) and Akt (Fig 5B) phos-
phorylation, but tempol did not alter the phosphorylation of these molecules under this experi-
mental condition. High D-glucose increased p42/44mapk, but not Akt phosphorylation, which
was reduced by insulin or tempol.
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Fig 2. Insulin modulation of kinetic parameters for saturable L-arginine transport in response to high
D-glucose. A, Saturable L-arginine transport (0–1000 μmol/L L-arginine, 2 μCi/mL L-[3H]arginine, 1 minute,
37°C) in HUVECs preincubated (24 hours) in Krebs solution containing 5 mmol/L D-glucose (control) or
25 mmol/L D-glucose + insulin. B, Maximal transport capacity (Vmax/Km) values for saturable L-arginine
transport from data in A. *P<0.04 versus values in the absence of insulin. Values are mean ± S.E.M. (n = 12–
15).
doi:10.1371/journal.pone.0122398.g002
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Role of NADPH oxidase on hCAT-1 expression
Apocynin blocked the increase in hCAT-1 protein abundance (Fig 5C), hCAT-1mRNA ex-
pression (Fig 5D), and SLC7A1 promoter activity caused by high D-glucose in cells transfected
with the pGL3-hCAT1-650 construct (Fig 5E). However, the increase in these parameters
caused by insulin in cells in 5 mmol/L D-glucose was unaltered by this inhibitor.
Fig 3. Insulin blocks high D-glucose-increase in hCAT-1 expression. A, Western blot for hCAT-1 protein abundance in whole HUVECs extracts
incubated (24 hours) in 5 or 25 mmol/L D-glucose in the absence (–) or presence of insulin. Lower panel: hCAT-1/β-actin ratio densitometries normalized to 1
in 5 mmol/L D-glucose in the absence of insulin. β -Actin is internal reference. B, Immunocytochemistry of hCAT-1 (green fluorescence) in cells as in A.
Control are cells in the absence of insulin. Bar indicates 5 μm at 60x microscopy magnification. C, Number of copies of hCAT-1mRNA and 28S rRNA
(internal reference) in cells as in A. D, Number of copies of hCAT-1 mRNA and 28S rRNA in cells incubated (24 hours) with 5 or 25 mmol/L D-glucose in the
absence (–) or presence of actinomycin D. E, Luciferase reporter construct containing two truncations of SLC7A1 promoter (-1606 bp (pGL3-hCAT-1-1606)
and -650 bp (pGL3-hCAT-1-650) from ATG) were transfected in HUVECs primary cultures as in A. In A, C and E, *P<0.04 or †P<0.05 versus 5 mmol/L D-
glucose in the absence of insulin. In C, *P<0.03 versus all other values. Values are mean ± S.E.M. (n = 5).
doi:10.1371/journal.pone.0122398.g003
Fig 4. High D-glucose–modulation of ROS, O2•– and BH4 generation. A, Reactive oxygen species (ROS) in HUVECs pre-incubated (24 hours) with D-
glucose at different concentrations. Relative fluorescence units (RFU) was measured in cells preloaded (30 minutes) with 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate (DCF) in the absence or presence of apocynin or insulin. Control is fluorescence in cells in 5 mmol/L D-glucose in the
absence of insulin or apocynin. Left panel. ROS level (as DCF fluorescence) in the absence (–) or presence (+) of apocynin or insulin in cells incubated with 5
or 25 mmol/L D-glucose. Bar indicates 200 μm at 10x microscopy magnification. B, The superoxide anion (O2
•–) level in cells pre-incubated (24 hours) with 5
or 25 mmol/L D-glucose in the absence (–) or presence (+) of 1 nmol/L insulin, 100 μmol/L apocynin or 1 mmol/L tempol, measured as relative luminescence
units (RLU) in cells preloaded (30 minutes) with 10 μmol/L lucigenin. C, Nitric oxide (NO) level in cells as in B, measured as RFU in cells preloaded (30
minutes) with 4-amino-5-methylamino-2',7'-difluorofluorescein. D, BH4 level measured by HPLC in cells as in B, and in the absence or presence of 100 μmol/
L Mn(III)TMPyP (TMPyP). In A, *P<0.03 versus Control. †P<0.04 versus corresponding values in 25 mmol/L D-glucose. In B, *P<0.03 versus all other
values. In C, *P<0.03 versus corresponding values in the absence of insulin, apocynin or tempol. In D, *P<0.05 versus corresponding values in 5 mmol/L D-
glucose, †P<0.03 versus corresponding values in the absence of insulin, apocynin, tempol or Mn(III)TMPyP. Values are mean ± S.E.M. (n = 4–7).
doi:10.1371/journal.pone.0122398.g004
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Fig 5. Apocynin blocks high D-glucose, but not insulin-increase in hCAT-1 expression and SLC7A1 promoter activity. A, Western blot for total (Total
p42/44mapk) or phosphorylated p42/44mapk (P~p42/44mapk) protein abundance in HUVECs incubated (24 hours) in 5 or 25 mmol/L D-glucose in the absence
(–) or presence (+) of 1 nmol/L insulin or 1 mmol/L tempol. β -Actin is internal reference. Lower panel: P~p42/44mapk/Total p42/44mapk ratio densitometries
normalized to 1 in 5 mmol/L D-glucose in the absence of insulin or tempol. B, Western blot for total (Total Akt) or phosphorylated Akt (P~Akt) protein
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Effect of D-glucose on vascular reactivity
Incubation of human umbilical vein rings with high D-glucose for 24 hours caused a higher
maximal contraction in response to U46619, compared with vein rings in 5 mmol/L D-glucose
(Fig 6A). The SC50 for the U46619 effect in high D-glucose (24.5 ± 0.6 nmol/L) was lower
(P< 0.05) than that in 5 mmol/L D-glucose (62.3 ± 0.9 nmol/L). Insulin, apocynin and tempol
blocked the U46619-increased contraction in high D-glucose (Fig 6B). Umbilical vein rings in
high D-glucose show reduced maximal dilation in response to CGRP compared with vein rings
in 5 mmol/L D-glucose (Fig 6C). The half-effective concentration (EC50) for the CGRP vasodi-
lation was similar in both experimental conditions (9.7 ± 0.2 and 9.6 ± 0.2 nmol/L for 5 and
25 mmol/L D-glucose, respectively). Insulin, but not apocynin or tempol increased vein rings
dilation in 5 mmol/L D-glucose; however, these molecules reversed the high D-glucose–de-
creased vein rings dilation (Fig 6D). In addition, 20 mmol/L D-mannitol + 5 mmol/L D-glu-
cose did not alter vascular reactivity to U46619 or CGRP (not shown).
Discussion
This study shows that high extracellular D-glucose increases L-arginine transport, NO synthe-
sis and O2
•– generation through eNOS and NADPH oxidase activation. Additionally, high D-
glucose increased the contractile response to U46619 in umbilical vein rings. Insulin reversed
these effects of high D-glucose, leading to normal hCAT-1 expression, NO synthesis, O2
•– gen-
eration and vasorelaxation. Insulin and tempol restored high D-glucose–increased p42/44mapk
activation. Insulin acts as a protective factor for fetoplacental vascular dysfunction by reducing
the oxidative stress caused by high D-glucose.
D-Glucose caused a biphasic increase in L-arginine transport with a half-maximal primary
peak stimulation of L-arginine transport (ppSE50) by 10 and 15 mmol/L D-glucose at longer
time of incubation (~2-fold) than for 20 and 25 mmol/L D-glucose. Thus, ppSC50 at higher and
lower D-glucose concentrations may result from different mechanism(s). Cells exposed for
24 hours to high D-glucose exhibited a ppSE50 value similar to that observed upon the increase
in hCAT-1 protein abundance, suggesting that high D-glucose-mediated increased L-arginine
transport likely occurred due to a higher hCAT-1 level. Because at the half-maximal secondary
peak stimulation of transport (spSC50) values were similar for all D-glucose concentrations, ei-
ther a mixture of mechanisms or different mechanisms may account for this phenomenon;
however, there was still an increase in hCAT-1 protein abundance in HUVECs. Interestingly,
increased hCAT-1 expression does not seem to be involved in the increased L-arginine trans-
port reported in response to 25 mmol/L D-glucose for 48 hours in human aortic endothelial
cells (HAECs) [25]. Thus, modulation of L-arginine transport by high D-glucose could be dif-
ferent depending on the source of human macrovascular endothelium. High D-glucose also
caused a biphasic increase in hCAT-1mRNA expression with ppSE50 and
spSE50 occurring earli-
er than for L-arginine transport (72 ± 12 and 78 ± 8 minutes, respectively), and ppSE50
abundance as in A. Lower panel: P~Akt/Total Akt ratio densitometries normalized to 1 in 5 mmol/L D-glucose in the absence of insulin or tempol. C, Western
blot for hCAT-1 protein abundance in the absence (–) or presence of insulin, without (–Apo) (Control) or with (+Apo) 100 μmol/L apocynin. Lower panel:
hCAT-1/β-actin ratio densitometries normalized to 1 in 5 mmol/L D-glucose in the absence of insulin or apocynin. Bars are cells without (–Apocynin) or with
100 μmol/L apocynin (+Apocynin). D, Number of copies of hCAT-1mRNA and 28S rRNA (internal reference) in cells as in C. E, Luciferase reporter construct
activity for cells transfected with a truncated SLC7A1 promoter (-650 bp (pGL3-hCAT-1-650) from ATG) as in C. In A–B, *P<0.04 versus all other
corresponding values in 5 or 25 mmol/L D-glucose. †P<0.05 versus 5 mmol/L D-glucose in the absence of insulin and tempol. In C–E, *P<0.05 versus
corresponding values in the absence of insulin and apocynin. †P<0.05 versus corresponding value in 25 mmol/L D-glucose in the absence of apocynin.
Values are mean ± S.E.M. (n = 5–6).
doi:10.1371/journal.pone.0122398.g005
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occurring earlier than hCAT-1 protein abundance (78 ± 7 minutes). No reports are available
that address the potential half-life of the hCAT-1 protein and hCAT-1mRNA in human endo-
thelial cells [11]. The CAT-1mRNA half-life was 90–250 minutes in the rat hepatoma FTO2B
cell line [26] and approximately 75 minutes in the stably transfected rat glioma C6 cell line
[27]. In addition, CAT-1mRNA turnover in response to amino acid deprivation increased be-
tween 6– 12 hours. Thus, hCAT-1mRNA turnover would be approximately 12 hours in re-
sponse to high D-glucose, with a half-life of 1–2 hours in HUVECs in 5 mmol/L D-glucose in
the absence of insulin. After challenge with high D-glucose, the hCAT-1mRNA turnover kinet-
ics could be extended to approximately 6–12 hour cycles.
Fig 6. Apocynin, tempol and insulin block high D-glucose effect on human umbilical vein ring reactivity. A, Response of human umbilical vein rings to
U46619 incubated (5 minutes) in 5 or 25 mmol/L D-glucose (24 hours). Relative responses are given as a percentage fraction of the initial vessel response to
KCl (see Methods). B, Maximal response of umbilical vein rings to 100 nmol/L U46619 as in A in the absence (–) or presence (+) of 1 nmol/L insulin,
100 μmol/L apocynin or 1 mmol/L tempol. C, Response of vein rings to CGRP as in A. D, Maximal response to 10 nmol/L CGRP as in B. In A and C, *P<0.03
versus corresponding values at lower concentrations of either U46619 or CGRP. †P<0.05 versus corresponding values in 25 mmol/L D-glucose. In B,
*P<0.02 versus all other values. In D, *P<0.02 versus all other corresponding values. Values are mean ± S.E.M. (n = 4–7).
doi:10.1371/journal.pone.0122398.g006
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Insulin increases L-arginine transport and NO synthesis involving protein kinase B (PKB)/
Akt in HAECs [25]. Incubation of HAECs with 25 mmol/L D-glucose increased L-arginine
transport, which is blocked by 1 nmol/L insulin. High D-glucose–increased hCAT-1 protein
abundance, and activity in HUVECs was also blocked by insulin; however, the insulin effect
was observed at a lower concentration (~10-fold) in HUVECs than in HAECs, with IC50 close
to insulinemia in human umbilical vein (~0.041 nmol/L) [28] and whole umbilical cord
(~0.025 nmol/L) [29, 30]. Thus, HUVECs are highly sensitive to insulin compared with
HAECs. Insulin also restored the high D-glucose-mediated increase in Vmax/Km, suggesting a
lower number of membrane transporters rather than reduced affinity of a fixed number of
transporters [11, 18]. Indeed, insulin restored hCAT-1 protein abundance and the plasma
membrane/cytosol distribution. Temporality in changes mediated by high D-glucose in hCAT-
1 protein abundance and activity are similar; thus, increased transport caused by high D-glu-
cose could result from higher hCAT-1 protein abundance, preferentially localised at the plasma
membrane in HUVECs. High D-glucose–associated changes in hCAT-1 expression could re-
sult from transcriptional and/or post-transcriptional modulation by insulin. In fact, the insulin
effect requires transcriptional regulatory factors acting at the -650 bp fragment of the promoter
region of SLC7A1. Specific protein 1 (Sp1) mediates insulin effects in several cell types, similar
to other TATA-less promoters [11, 31, 32], including increased SLC7A1 transcriptional activity
in HUVECs [12]. SLC7A1 exhibits at least four Sp1 consensus sequences between -177 and
-105 bp from its translation start point in HUVECs [11, 12], making it likely that insulin-re-
stored SLC7A1 promoter activity results from reduced Sp1 activity. However, other transcrip-
tion factor(s) that reduce SLC7A1 transcriptional activity, such as the C/EBP homologous
protein 10 (CHOP) as reported in C6 rat glioma cells [33], may be involved in mediating
insulin effects.
NADPH oxidase generates ROS in HUVECs exposed to hyperglycemia [18]. We showed
that high D-glucose increases ROS generation with a SC50 value of approximately 11 mmol/L,
which is similar to the stimulatory effect by high D-glucose on L-arginine transport (SC50 of
~13 mmol/L). Thus, the high D-glucose–mediated increase in ROS generation could lead to in-
creased L-arginine transport in HUVECs. Because ROS generation was blocked by apocynin,
high D-glucose activation of NAPDH oxidase is feasible, agreeing with findings in human um-
bilical artery endothelium exposed to 30 mmol/L D-glucose [34] and in EAhy926 cells (immor-
talised endothelial cell line) exposed to 35 mmol/L D-glucose [35]. Apocynin blocked the high
D-glucose-mediated increase in ROS and O2
•– generation in similar proportions (~69 and
~83%, respectively), suggesting that O2
•– is the main form of NADPH oxidase-generated ROS
(~82%). The latter was further supported by the results showing that the SOD mimetic tempol
reduced the effect of high D-glucose in O2
•– generation. Interestingly, insulin blocked ROS and
O2
•– generation under high D-glucose; thus, a potential anti-oxidative stress role for insulin by
decreasing NADPH oxidase activity is feasible in HUVECs, which agrees with findings in
mesenteric arterioles from diabetic rats [36]. However, since HUVECs exposed to high D-glu-
cose increases mitochondrial O2
•– generation [37], the possibility that insulin also modulates
this source of O2
•– generation is likely.
Insulin and tempol reversed the high D-glucose–increase in p42/44mapk phosphorylation,
suggesting that cell signalling mediated by activation of these protein kinases could result from
a higher O2
•– generation under high D-glucose. In addition, a potential protective effect of in-
sulin in this phenomenon is feasible. On the contrary, since high D-glucose did not alter Akt
phosphorylation it is likely that this molecule is not involved in the response to this environ-
mental condition enriched in O2
•– in HUVECs from normal pregnancies. The insulin response
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in this study is similar to that reported in primary cultures of HUVECs from GDM pregnancies
[38]. Since GDM associates with overexpression of insulin receptor A (IR-A) form in
HUVECs, and activation of these receptors leads to preferential p42/44mapk phosphorylation
compared with Akt phosphorylation in HUVECs from normal pregnancies, it is feasible that
insulin mediates similar mechanisms to restore p42/44mapk associated cell signalling in a high
D-glucose environment and in GDM.
High D-glucose caused comparable increases in NO and ROS generation; thus, these phe-
nomena are linked in HUVECs, agreeing with a report on this cell type when it was incubated
with 75 mmol/L D-glucose [39]. The high D-glucose-mediated increase in NO synthesis is
NADPH oxidase-independent, as apocynin was ineffective. However, because insulin blocked
the D-glucose effect on NO synthesis and ROS generation, an alternative mechanism for the re-
sponse to this hormone in HUVECs is likely. Thus, insulin could be equally active in prevent-
ing O2
•– oxidative stress in HUVECs under high D-glucose conditions. eNOS uncoupling due
to imbalanced tetrahydrobiopterin (BH4) and dihydrobiopterin (BH2) levels (BH2/BH4> 1)
leads to O2
•– generation [40]. Paradoxically, even when high D-glucose causes an increase in
the NO level, our results also show that BH4 level is lower under this condition, supporting the
possibility that at least a fraction of eNOS could be uncoupled in high D-glucose. Since only
the SOD mimetics tempol and Mn(III)TMPyP increased the BH4 level to comparable values in
cells in 5 or 25 mmol/L D-glucose it is likely that O2
•– generation by HUVECs in both of these
experimental conditions maintains a lower expression of this cofactor. In fact, O2
•– generated
by NADPH oxidase is unlikely since apocynin did not reverse the reduced BH4 level detected
in cells in high D-glucose. Thus, an alternative to NADPH oxidase-generated O2
•– by high D-
glucose is eNOS uncoupling in HUVECs. The latter hypothesis is further supported by (a) a
better correlation between the NO level and O2
•– generation observed in response to 25
mmol/L compared with 5 mmol/L D-glucose ((NO/O2
•–)25 mmol/L/(NO/O2
•–)5 mmol/L = 1.22),
(b) increased NADPH-dependent O2
•– generation by reducing the eNOS dimer/monomer
ratio (i.e., uncoupled eNOS) and NO synthesis in EA.hy926 cells exposed to 35 mmol/L D-glu-
cose [35], (c) restoration of eNOS dimerization and function by BH4 administration in diabetic
rats [36] and (d) restoration by apocynin of the diabetes mellitus-increased eNOS-derived O2
•–
in mice [41]. Taking in consideration that incubation of HUVECs with ~22.5 mmol/L D-glu-
cose causes an estimated increase of ~2.3 fold of the peroxynitrite (ONOO–) level [42], a me-
tabolite that results from the reaction between NO and O2
•–, and since in our study the
increase in NO level (~1.8 fold) and O2
•– generation (~2.1 fold) were similar, we speculate on
the possibility that ONOO– generation is likely increased in ~2 fold in HUVECs exposed to
high D-glucose. In addition, insulin caused a comparable reduction (~32%) in NO level and
O2
•– generation in cells in high D-glucose, suggesting the possibility that this hormone could
also cause a reduction in ONOO– generation in HUVECs. However, since apocynin or tempol
restored the high D-glucose–elevated O2
•– generation, but not the increase in the NO level to
values in cells in 5 mmol/L D-glucose, O2
•– generation from NADPH oxidase may not be
enough to cause an increase in the ONOO– generation in high D-glucose in this cell type.
Increases in hCAT-1 protein abundance, hCAT-1mRNA expression and SLC7A1 promoter
activity by high D-glucose, but not insulin, were blocked by apocynin, suggesting a NADPH
oxidase-dependent mechanism. It has been reported that eNOS activity is associated with
higher hCAT-1–mediated L-arginine transport in EA.hy926 cells [13]. Because insulin blocked
the increase in Vmax/Km for L-arginine transport but reduced the high-D-glucose-mediated in-
crease in the NO level by ~63%, the high D-glucose effect was partially dependent (~25–30%)
on L-arginine transport in HUVECs. In addition, lower hCAT-1 protein abundance compared
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with reduced Vmax/Km could be mainly responsible (~75%) for the insulin-mediated reversal of
NO synthesis. Our findings also show that insulin reduced hCAT-1 protein abundance at the
plasma membrane at high D-glucose concentrations. Because insulin increased hCAT-1 pro-
tein abundance in membrane fractions in HUVECs in 5 mmol/L D-glucose [12] and caused a
general increase in its cellular distribution in this cell type, reduced hCAT-1 protein abundance
at the plasma membrane in cells challenged with high D-glucose could be caused by insulin.
These findings support the possibility that not only a reduction in the total protein abundance
but also potential hCAT-1 redistribution results from incubation with high D-glucose and in-
sulin. The opposite response to insulin regarding hCAT-1 activity and expression in HUVECs
in 5 mmol/L versus 25 mmol/L D-glucose is a finding that is similar to the differential response
to this hormone reported for eNOS expression and activity as well as for the human equilibra-
tive nucleoside transporter 1 (hENT1) expression and activity in HUVECs from normal preg-
nancies compared with GDM pregnancies [38]. The mechanisms behind these opposite effects
of insulin involve activation of A1 and A2A adenosine receptors leading to modulation of the bi-
ological effect of insulin in HUVECs from normal pregnancies [18], GDM pregnancies [38],
and in preeclampsia [43]. These mechanisms were not evaluated in this study; however, it is
suggested that insulin could use an intracellular metabolic machinery to modulate expression
of SLC29A7 and hCAT-1 protein that is different in HUVECs in a normal or high D-glucose
environment, as reported in GDM [44].
Umbilical vein contraction was caused by the thromboxane A2 mimetic U46619, as reported
in human chorionic plate arteries [24]. The U46619 maximal contraction in high D-glucose
conditions was higher (~1.8-fold) compared with 5 mmol/L D-glucose, suggesting that reduced
bioavailability of agents causing vasorelaxation or increased agents causing vasoconstriction
may be responsible for this phenomenon. Interestingly, U46619 half-maximal constriction in
high D-glucose was higher than in 5 mmol/L D-glucose (25 mmol/LSC50/
5 mmol/LSC50 = 2.5), sug-
gesting that under high D-glucose, umbilical vein rings are more reactive to this molecule than
preparations in a physiological concentration of D-glucose. It is likely that increased contrac-
tion of umbilical vein rings in high D-glucose conditions occurred due to increased ROS and
O2
•– generation because this vascular response was blocked by insulin, apocynin and tempol.
Since similar results were found in the response of umbilical vein rings to CGRP (a preferential
endothelium-dependent vasodilator), not only constriction, but also dilation are altered involv-
ing similar mechanisms in terms of oxidative stress in vein rings exposed to high D-glucose.
Interestingly, since CGRP half-maximal dilation in high D-glucose was similar to that in
5 mmol/L D-glucose (25 mmol/LEC50/
5 mmol/LEC50 = 1.02), a reduced sensibility to vasodilators is
unlikely to be the cause of the high D-glucose–increased vasoconstriction in human umbilical
vein rings.
HUVECs exposure to high D-glucose increases L-arginine transport (Fig 7), likely resulting
from higher hCAT-1 expression and protein abundance in the plasma membrane. This mecha-
nism could be an adaptive response of HUVECs to higher ROS and O2
•– generation from high
D-glucose–activated NADPH oxidase. In parallel, high D-glucose increased NO synthesis,
which was independent of NADPH oxidase activation. Insulin reversed the high D-glucose-
mediated alterations in L-arginine transport involving the modulation of SLC7A1 gene expres-
sion, leading to altered umbilical vein reactivity. Modulation of hCAT-1 expression and activity
is key to maintaining umbilical vein tone and endothelial function. Most diseases of pregnancy
progress with oxidative stress leading to altered placental vascular reactivity [11]. Thus, man-
agement of potential pro-oxidative stress conditions is necessary to prevent fetoplacental endo-
thelial dysfunction, thus ensuring an adequate supply of nutrients to the growing foetus.
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Fig 7. Involvement of high D-glucose–increased oxidative stress on L-arginine transport in human umbilical vein endothelium. A, Exposure of
HUVECs to 25 mmol/L D-glucose (High D-glucose) leads to an increase (⇧) in the plasmamembrane abundance of the human cationic amino acid
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